Samira Behboudi‐Gandevani

ORCID: 0000-0003-3526-640X · 5 papers in corpus
review 2026
Frontiers in global women's health ·doi:10.3389/fgwh.2026.1895443

Endometriosis is frequently managed with hormonal suppression that can induce hypoestrogenism during a period when many patients are still accruing peak bone mass. This narrative review summarizes current clinical and mechanistic evidence o…

observational 2025
BMJ open ·doi:10.1136/bmjopen-2025-102774

BACKGROUND: While previous studies have shown an association between anti-Mullerian hormone (AMH) levels and endometriosis, there are limited data on the relationship between AMH levels and age among women with endometriosis. OBJECTIVES: T…

observational 2025
·doi:10.1093/humrep/deaf097.616

Abstract Study question What is the relationship between age and Anti-Mullerian Hormone (AMH) levels in women with and without endometriosis? Summary answer AMH levels decreased with age in both groups, but declined consistently in women wi…

meta-analysis 2025
Health science reports ·doi:10.1002/hsr2.71626

BACKGROUND AND AIMS: The COVID-19 pandemic has significantly affected public health worldwide. This study applies a novel Robust Bayesian Model Averaging-Publication Selection Model Averaging method (RoBMA-PSMA) to address publication bias …

observational 2015
Global journal of health science ·doi:10.5539/gjhs.v7n6p226

BackgroundPrimary infertility is a health issue among women over the world. The aim of this study was to investigate the prevalence and causes of primary infertility based on a population-based study in an urban area of Iran.Materials and m…